INS and Hypoglycemia: SGLT 2 inhibitors are newer anti-hyperglycemic agents, which improve glycemic control independent of insulin secretion with a low risk of hypoglycemia.13 There is limited data on use of SGLT 2 inhibitors in Pakistan; this is a case series of local patients treated with SGLT 2 inhibitors.